I am/have/had
I am looking for
Advanced Filters
Found 191 clinical trials
Cetuximab Therapeutic Drug Monitoring in Squamous Cell Carcinoma Head and Neck Cancer Patients: Determination of the Predictive Value Exposure Levels Through a Single Arm Multicentric Study
Only about 30 percent of cancer patients have a clinical benefit upon cetuximab administration. Pilot studies in colorectal and head and neck cancer patients have suggested that cetuximab pharmacokinetics (PK), i.e. clearance values, could impact on clinical outcomes such as survival. Determining cetuximab plasma clearance requires sophisticated PK modeling using …
squamous cell carcinoma of head and neck
cancer
squamous cell carcinoma
fluorouracil
cetuximab
- 0 views
- 19 Feb, 2024
- 1 location